Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2014
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms PULS
- Sponsors Takeda Pharmaceuticals International GmbH
- 07 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.
- 01 Sep 2010 Actual end date changed from Dec 2008 to Apr 2009 as reported by ClinicalTrials.gov.
- 17 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.